Deputy Qualified Person for Pharmacovigilance (dQPPV) to Intervacc AB

At Intervacc, we believe there is an urgent need to develop better vaccines to prevent the spread of the infectious diseases of today and tomorrow. We believe in the vision of One Health and that in order to create a healthier world we need to look at the system as a whole to fight existing and new infectious diseases in animals as well as in humans. We need to combat zoonotic diseases and we reduce the global threat from antimicrobial resistance. We are dedicated to developing safe, effective and practical vaccines within animal health, and to bring these vaccines to the global market. This is our passion and our mission.

We are now looking for a dQPPV to take a leading role in ensuring the safety, compliance, and regulatory standards of our innovative vaccine portfolio. In this exciting role, you will have the responsibility of overseeing the safety profile of our vaccine products and ensuring full compliance with the EU 2019/6 veterinary regulation. You will play a key part in maintaining our Pharmacovigilance System Master File (PSMF) and drive continuous improvement in our safety monitoring processes. Importantly, you will have the opportunity to work with dedicated, friendly and competent colleagues at a company with an exciting journey ahead. If this sounds interesting to you – come join us!

Intervacc AB is headquartered in Stockholm Sweden and is listed on the Swedish Nasdaq First North Growth Market. The position is full-time, and we welcome your application today!

Key Responsibilities

As dQPPV, your main responsibilities and tasks include:

• Maintaining and continuously updating the Pharmacovigilance System Master File (PSMF).

• Ensuring systems and processes are in place to collect, manage and record all suspected adverse events.

• Applying and overseeing the signal management process and ensuring responsibilities related to the benefit–risk balance of our products.

• Managing the pharmacovigilance system, including quality control, audits, compliance tracking, and business continuity.

• Staying up to date on relevant pharmacovigilance regulations.

• Ensuring necessary SOPs for pharmacovigilance are in place, current and compliant.

• Responding to customer or field inquiries related to product safety

Skills and Competencies

The suitable candidate has the following qualifications:

• A formal academic degree in a science-related field

• Several years of experience in pharmacovigilance within a pharmaceutical or biotechnology company, preferably as dQPPV or QPPV.

• Experience in vaccine products or veterinary medicinal products is merited

• Experience participating in or leading inspections or PV-related audits.

• Practical experience developing or improving PV processes and systems.

• Experience in Medical Information is meritorious.

The successful candidate for this position will be someone who:

• Takes ownership and accountability to drive continuous improvement of the PV system

• Has a good eye for detail and a thorough approach to work

• Is a proactive, flexible, motivated and ambitious team player

• Is adaptable to change

If you are ready to bring your expertise in pharmacovigilance, we are ready to offer you an excellent career opportunity at an innovative company with an exciting journey ahead!

About Intervacc

Intervacc is an innovative Swedish biotechnology company that develops and markets modern, effective, and safe vaccines against bacterial infections affecting animals. Over the past decade, advances in molecular biology techniques have significantly enhanced our ability to investigate the genomes of pathogenic bacteria. Building on our research foundations at the Karolinska Institutet and the Swedish University of Agricultural Sciences, we have developed a technology platform for a new generation of vaccines. Our first proprietary vaccine, a vaccine against strangles, a severe bacterial respiratory disease, which affects horses—is now available in several European markets. The Intervacc share (STO: IVACC) is listed on the NASDAQ First North Growth Market and our headquarter is in Stockholm, Sweden. You can find more information about Intervacc at www.intervacc.se